Eyepoint Bio
Business Services · Massachusetts, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
480 Pleasant St Ste C400, Watertown, Mas...Website
eyepoint.bioRevenue
<$5 MillionStock Symbol
EYPTIndustry
About Eyepoint Bio
Eyepoint Bio Org Chart
Is Eyepoint Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Eyepoint Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Eyepoint Bio had a recent Job posting/layoffs
Earning: See what the market has to say on Eyepoint Bio recently announced quarterly report
Funding: Get notified immidiatlly once Eyepoint Bio has new funding data
Congratulate Masked Content for being promoted to Masked Content at Eyepoint Bio
Product Launch: Get notified when Eyepoint Bio launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Eyepoint Bio has recently received funding, and reach out quickly before it becomes old news!
Check out if Eyepoint Bio is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Eyepoint Bio as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Eyepoint Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Eyepoint Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Eyepoint Bio.
Eyepoint Bio News & Media
Kessler Topaz Meltzer & Check, LLP Encourages EyePoint, Inc. (NASDAQ: EYPT) Investors to Contact the Firm
RADNOR, Pa., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by EyePoint, Inc. (NASDAQ: EYPT) on behalf of investors who purchased or acquired EyePoint, Inc. securities and experienced significant financial losses.EyePoint Pharmaceuticals (EYPT) Securities Investigation Notice - Levi & Korsinsky
EyePoint Pharmaceuticals shares opened down approximately 70% after the Company disclosed that DURAVYU missed the prespecified primary endpoint in the Phase 3 LUGANO trial. Levi & Korsinsky is investigating on behalf of EYPT investors who lost money. NEW YORK, Aug. 26, 2026 /PRNewswire/...INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
NEW YORK, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of EyePoint, Inc. (“EyePoint” or the “Company”) (NASDAQ: EYPT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving EyePoint Pharmaceuticals (EYPT)
DURAVYU's Phase 3 LUGANO trial missed its prespecified primary endpoint, and EYPT shares lost nearly 67% of their value in a single session. Levi & Korsinsky is investigating on behalf of shareholders who may have legal rights arising from those losses DURAVYU's Phase 3 LUGANO trial missed its prespecified primary endpoint, and EYPT shares lost nearly 67% of their value in a single session. Levi & Korsinsky is investigating on behalf of shareholders who may
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Eyepoint Bio
Eyepoint.bio is a forward-thinking biotechnology company focused on advancing precision health through innovative bioinformatics and data-driven discovery. The company integrates cutting-edge computational biology with real-world clinical insights to accelerate the development of targeted therapies and diagnostics. By leveraging large-scale biologi... Read More